Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 2.7800
- +0.1700+6.51%
Close Feb 28 16:00 ET
- 2.7700
- -0.0100-0.36%
Post 20:01 ET
187.89MMarket Cap-1.87P/E (TTM)
2.8050High2.6150Low1.61MVolume2.6800Open2.6100Pre Close4.45MTurnover3.34%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.57P/B133.71MFloat Cap2.360052wk Low--Dividend TTM48.10MShs Float85.0000Historical High--Div YieldTTM7.28%Amplitude0.0300Historical Low2.7660Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. Spoor
MarketAMEX
Employees119
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. Spoor
- Director and Chief Executive Officer
- 1.46M
- Jonathan R. Hunt
- Chief Accounting Officer
- 1.17M
- Juan Graham
- Chief Financial Officer
- --
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
- Robert Froman Willian, III
- Independent Director
- 320.06K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K